Howard G. Welgus, Director at Arcutis Biotherapeutics, Inc. (ARQT), sold 18,416 shares at $13.84 ($255K) on 2025-07-01, disclosed to the SEC on 2025-07-02.
Scheduled sale ($255k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.84 | 9,208 | $127K | 50.0% |
| 2 | $13.84 | 9,208 | $127K | 50.0% |
| Total | $13.84 avg | 18,416 | $255K | 100% |
| Filing → |
| ARQT | SELL | 2026-07-17 | $127K | — | Filing → |
| ARQT | SELL | 2026-06-17 | $116K | — | Filing → |
| ARQT | SELL | 2026-05-05 | $164K | — | Filing → |